hepatocellular carcinoma, large language model, artificial intelligence, clinical decision-making, survival analysis
Hepatocellular carcinoma, Machine Learning, Atezolizumab-bevacizumab, Hepatic decompensation, Variceal bleeding, Portal hypertension